Ultrasound Guided Femoral Nerve Block

Completed · Not applicable

Conditions studied: Hip Fracture

In brief

The goal of the study is to evaluate whether pain control achieved by Ultrasound Guided Femoral Nerve Blockade (USFNB) is equal in efficacy to standard pain management practice of parenteral injection of opioid pain medication in patients presenting to the emergency department (ED) with hip fracture.

Key facts

Study ID

NCT02381717

Run by

Beth Israel Deaconess Medical Center

People needed

44

Starts

2015-08-01

Expected to finish

2025-12-01

Last updated by the study team

2026-03-03

Who can join

Age: 18 and older, up to 101. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients over 18 years of age presenting to the ED with radiographically established intra-, extracapsular hip fracture, able to consent and participate in the study and who have moderate to severe pain (numerical pain score >= 31) at the time of enrollment.

You may not qualify if…

• Patients with a previous history of hypersensitivity to local anesthetics,
• Patients who have signs of a local infection at the site of planned needle placement.
• INR > 1.4NOAC use within 48 hours
• Prophylactic Low-Molecular Weight Heparin (LMWH) within 12 hours
• Therapeutic LMWH within 24 hours
• Prophylactic Unfractionated Heparin (5000 Units BID or TID) within 6 hours

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• St. Vincent's Hospital — Worcester, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.